Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT)

CUSIP: 097702104

Q1 2022 13F Holders as of 31 Mar 2022

Holder snapshot 6 signals
Share change
-4,683,920
SEC-reported price per share
$2.74
Number of holders
62
Value change
-$19,556,970
Number of buys
26
Number of sells
34
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
38,512,859

Security key

097702104

Report period

Q1 2022

Institutions

62

Top holders

10

Ownership snapshot

Top reported holders of BOLT - Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Novo Holdings A/S
Disclosed value leader
Novo Holdings A/S
Comparable rows
0/15
Latest evidence
31 Dec 2021
13F Highest disclosed value: $22,070,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Novo Holdings A/S has the largest disclosed position value at $22.07M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Novo Holdings A/S's linked filing trail.
Disclosed position value Top 5
Novo Holdings A/S $22.07M
Vivo Capital, LLC $18.97M
CITADEL ADVISORS LLC $13.78M
Sofinnova Investments, Inc. $13.5M
RA CAPITAL MANAGEMENT, L.P. $11.65M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Novo Holdings A/S
13F
Company
13F
—
denominator unverified
$22,070,000
4,503,991 shares
— 31 Dec 2021
Vivo Capital, LLC
13F
Company
13F
—
denominator unverified
$18,969,000
3,871,291 shares
— 31 Dec 2021
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$13,781,000
2,812,359 shares
— 31 Dec 2021
Sofinnova Investments, Inc.
13F
Company
13F
—
denominator unverified
$13,497,000
2,754,437 shares
— 31 Dec 2021
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$11,654,000
2,378,325 shares
— 31 Dec 2021
MONTANOVA CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$10,928,000
2,230,250 shares
— 31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
62
Shares
28,919,953
Rows available
62
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q3 2025 Across Filers

Q3 2025 holders
1
Q1 2022 holders
62
Holder diff
61
Investor Q3 2025 Shares Q1 2022 Shares Share Diff Share Chg % Q3 2025 value Q1 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .